The RANKL, derived from anti-tumor T cells, induces osteoclastogenesis, leading to an increase in bone resorption before the arrival of metastatic cells, generating a rich and ideal microenvironment for establishing these cells as a necessary pre-metastatic niche. The gene discussed is TNFSF11; the disease is neoplasm.